Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue

September 3, 2020 updated by: Andreia Noites, Escola Superior de Tecnologia da Saúde do Porto

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue in the Abdominal Region

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. The radiofrequency (RF) device has been shown to be safe and effective for non-invasive fat reduction, as well as cutaneous enhancement and improvement of skin flaccidity (BOISNIC, et al., 2014).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In Brazil, the search for satisfaction with self-image has been increasing, since the profile of the population has been altered by cultural factors such as industrialized foods with high caloric content and sedentary lifestyle. These factors result in the accumulation of adipose tissue in typical and atypical places, caused by the imbalance of the energy balance, that is, a higher caloric intake when compared to the energy consumption.

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. The radiofrequency (RF) device has been shown to be safe and effective for non-invasive fat reduction, as well as cutaneous enhancement and improvement of skin flaccidity (BOISNIC, et al., 2014).

Radiofrequency emits focused electromagnetic waves that find resistance in the tissue, generating heat (KRUEGUER, LEVY and SADICK, 2012). This thermal energy affects the triple helix structure of the collagen, subsequently breaking the intramolecular hydrogen bonds, resulting in immediate contraction of the collagen and neocollagenesis in the dermis, without interfering in the epidermis.

This neocollagenesis and remodeling of collagen results in a visibly compacted and organized dermis. Skin enhancement is an important effect, since patients that search for non-invasive fat reduction usually also seek improvement in skin flaccidity. This represents a substantial improvement over currently available technology (BOISNIC, et al, 2014).

There is controversy regarding the mechanism of fat mobilization. Some authors, after observing human skin cultures at the end of the series of RF treatments found a profound effect on subcutaneous adipocytes. The analysis resulted in altered morphology and increased expression of the pyroptosis marker, APAF-1, suggesting that pyroptosis induced by irreversible electroporation is the mechanism of action. Adipocyte pyroptosis results in the release of triglycerides from disintegrated cell membranes, but in a delayed and gradual manner, allowing a slow and safe removal through the interstitial space and liquid transport systems, lymphatic vessels and other metabolic functions. There was no evidence of necrosis or inflammatory changes observed in adipocytes after treatments with BodyFX, a type of radiofrequency (BOISNIC, et al, 2014).

Other authors say that the increase in temperature caused by RF has physiological effects, such as increased cellular metabolism, increased vasodilation and blood supply and activation of branches of the autonomic nervous system releasing adrenaline and noradrenaline (BELENKY, et al., 2012; PUMPRALA, et al., 2015, MESSINA, et al., 2017, RYDDEN and ARNER, 2017). These effects culminate in the better efficacy of lipolysis, which is a biochemical process where lipid hydrolysis occurs.

The evaluation and application of the protocol will be performed in the therapeutic resources laboratory of the physiotherapy course of Federal University of Triângulo Mineiro- UFTM (whose coordinator is the researcher responsible for this study), the material will be collected at the Clinical Hospital of the UFTM surgical center and the preparation and analysis of the slides will be carried out in the pathology laboratory of UFTM.

The women who will undergo plastic abdominoplasty surgery at the Clinical Hospital of the UFTM will be invited to participate in the study. These women are in the electronic queue awaiting surgery and will be invited by the plastic surgery team.

The volunteers will receive radiofrequency (TECAR-BTL® device, with epidermal temperature above 40ºC) in the right infraumbilical abdominal region, with an application time of 10 minutes (2 minutes per applicator area) and the left region will be used as control. A single session will be held. After approximately 30 days of this application the material for histological analysis will be collected during the surgical act, at which point the skin and the subcutaneous tissue of the infraumbilical region are discarded by the surgeon.

Fragments collected during surgery will be fixed in Methacarn (60% methanol, 30% chloroform, 10% acetic acid) for 2 hours at room temperature (RT). The slides will be made by the department of general pathology of the Federal University of the Triângulo Mineiro. Samples will be dehydrated in ethanol, diaphonized in xylol and embedded in paraffin. Histological sections of 5 μm thickness will be obtained in microtome (Jung) and placed on pre-coated sheets with polylysine. The histological sections will be stained with hematoxylin and eosin, Picro-sirius and Verhoeff. By the staining of Hematoxylin-Eosin will be analyzed the general morphology of the tissue including the quantity and volume of the adipose vacuoles, Picro-sirius the presence and morphology of the collagen fibers and Verhoeff the elastic fibers.

Blades stained by Hematoxylin-Eosin, Picro-sirius and Verhoeff will be visualized with a 20x objective. The images will be captured by a common light microscope and analyzed by the Axion Vision Automatic Image Analyzer System.

In this way the field to be quantified will be captured, photographed through a camera attached to the microscope and to the computer for image scanning. Images will be saved in TIFF format. All blade fields will be photographed and saved.

After the fields are saved, the Image J® program will be used to improve them, using the illumination reference so that they all have the same quality.

The percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole will be marked by the Image J® program and registered in a Microsoft Excel worksheet.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Uberaba
      • Minas Gerais, Uberaba, Brazil
        • Adriana mendonça

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women who will undergo plastic abdominoplasty surgery at the Clinical Hospital of the Federal UFTM.

Exclusion Criteria:

  • Sensitive and cognitive deficits
  • Aged less than 18 years
  • Metal implant at the application site
  • Pacemakers
  • Signs of infection
  • Circulatory disorders
  • Neoplasia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: RF
The right side will be treated with radiofrequency
The volunteers will receive radiofrequency (TECAR-BTL® device, with epidermal temperature above 40ºC) in the right infraumbilical abdominal region, with an application time of 10 minutes (2 minutes per applicator area) and the left region will be used as control. A single session will be held. After approximately 30 days of this application the material for histological analysis will be collected during the surgical act, at which point the skin and the subcutaneous tissue of the infraumbilical region are discarded by the surgeon.
Other Names:
  • Radiofrequency treatment
NO_INTERVENTION: NI
The left side will not receive treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole
Time Frame: 30 days
The percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole will be marked by the Image J® program and registered in a Microsoft Excel worksheet- For the variables percentage of collagen, elastic fibers, number of fibroblasts and number of adipocytes will be performed the normality test with Shapiro Wilk. The paired t test will be used when data are normal and Wilcoxon when not normal. The differences observed will be considered significant when the probability of rejection of the null hypothesis is less than 0.05.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 2, 2019

Primary Completion (ACTUAL)

April 24, 2020

Study Completion (ACTUAL)

July 31, 2020

Study Registration Dates

First Submitted

November 26, 2019

First Submitted That Met QC Criteria

November 29, 2019

First Posted (ACTUAL)

December 2, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2020

Last Update Submitted That Met QC Criteria

September 3, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • AN-010

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adiposity

Clinical Trials on Radiofrequency

3
Subscribe